Synaptic regulators, such as BDNF/tropomyosin receptor kinase B (TrkB), N-methyl-d-aspartate (NMDA), glutamate, estrogen, insulin, or their downstream signaling pathways, like PI3K/AKT/mTor are crucial therapeutic targets for depression [78]. Here, BDNF is linked to depressive disorder.